-
Something wrong with this record ?
Predictive characteristics of holter-based postinfarction risk stratifiers appear superior to electrophysiological testing
D Wichterle, J Simek, J Camm, M Malik
Language English Country United States
Document type Comparative Study, Research Support, Non-U.S. Gov't
Grant support
NR8146
MZ0
CEP Register
Digital library NLK
Full text - Část
Source
NLK
CINAHL Plus with Full Text (EBSCOhost)
from 1978-01-01 to 1 year ago
Medline Complete (EBSCOhost)
from 1978-01-01 to 1 year ago
Wiley Online Library (archiv)
from 1997-01-01 to 2012-12-31
PubMed
15683492
Knihovny.cz E-resources
- MeSH
- Electrophysiology MeSH
- Electrocardiography, Ambulatory * MeSH
- Risk Assessment MeSH
- Myocardial Infarction mortality physiopathology MeSH
- Middle Aged MeSH
- Humans MeSH
- Predictive Value of Tests MeSH
- Heart Rate * MeSH
- Check Tag
- Middle Aged MeSH
- Humans MeSH
- Male MeSH
- Female MeSH
- Publication type
- Research Support, Non-U.S. Gov't MeSH
- Comparative Study MeSH
Prevalent low-frequency (PLF) oscillation of heart rate and turbulence slope (TS) are both powerful postmyocardial infarction (MI) risk factors. Abnormal composite risk stratifier (CRS) was defined as abnormal PLF or abnormal TS when PLF was not analyzable. We compared the predictive power of CRS with the previously published predictive value of conventional electrophysiological (EP) testing based on the presence of nonsustained ventricular tachycardia (NSVT) and inducibility of sustained ventricular tachycardia/fibrillation (VT/VF) during programmed ventricular stimulation (PVS). PLF and TS were calculated from baseline Holter recordings in the placebo population of European Amiodarone Infarction Myocardial Infarction Trial (EMIAT trial) (n = 633; LVEF = 40%; 87 deaths; 22-month follow-up). Previously established cut-off values of PLF >/= 0.1 Hz and TS = 2.5 ms/RR were used. The clinical characteristics of the EMIAT population were similar to those of the Multicenter Unsustained Tachycardia Trial (MUSTT trial). Therefore, we compared the predictive power of CRS and conventional PVS using the values of 35% VT/VF inducibility during PVS in NSVT patients, and a 33% and 50% increase in all-cause and arrhythmic mortality, respectively, associated with VT/VF inducibility in MUSTT. Projecting the predictive power of PVS in MUSTT into the EMIAT population yielded a sensitivity of 13.8% and 14.0% and positive predictive value (PPV) of 27.9% and 14.0% for all-cause and arrhythmic mortality, respectively, whereas an abnormal CRS was associated with sensitivities of 46.0% and 46.5% and PPV of 37.4% and 18.7%. Compared with the noninvasive Holter-based CRS, invasive PVS appears inferior in the identification of high-risk post-MI patients with left ventricular dysfunction.
2nd Department of Internal Medicine General University Hospital Prague Czech Republic
3rd Department of Internal Medicine General University Hospital Prague Czech Republic
Department of Cardiac and Vascular Sciences St George's Hospital Medical School London UK
Euromise Cardio 1st Medical School Charles University Prague Czech Republic
Literatura
- 000
- 00000naa a2200000 a 4500
- 001
- bmc13031288
- 003
- CZ-PrNML
- 005
- 20131002101505.0
- 007
- ta
- 008
- 131001s2005 xxuad f 000 0|eng||
- 009
- AR
- 035 __
- $a (PubMed)15683492
- 040 __
- $a ABA008 $d ABA008 $e AACR2 $b cze
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Wichterle, Dan $7 xx0101417 $u Department of Cardiac and Vascular Sciences, St. George's Hospital Medical School, London, UK; Second Department of Internal Medicine, General University Hospital, Prague, Czech Republic; Euromise-Cardio, First Medical School, Charles University, Prague, Czech Republic
- 245 10
- $a Predictive characteristics of holter-based postinfarction risk stratifiers appear superior to electrophysiological testing / $c D Wichterle, J Simek, J Camm, M Malik
- 504 __
- $a Literatura
- 520 9_
- $a Prevalent low-frequency (PLF) oscillation of heart rate and turbulence slope (TS) are both powerful postmyocardial infarction (MI) risk factors. Abnormal composite risk stratifier (CRS) was defined as abnormal PLF or abnormal TS when PLF was not analyzable. We compared the predictive power of CRS with the previously published predictive value of conventional electrophysiological (EP) testing based on the presence of nonsustained ventricular tachycardia (NSVT) and inducibility of sustained ventricular tachycardia/fibrillation (VT/VF) during programmed ventricular stimulation (PVS). PLF and TS were calculated from baseline Holter recordings in the placebo population of European Amiodarone Infarction Myocardial Infarction Trial (EMIAT trial) (n = 633; LVEF </= 40%; 87 deaths; 22-month follow-up). Previously established cut-off values of PLF >/= 0.1 Hz and TS </= 2.5 ms/RR were used. The clinical characteristics of the EMIAT population were similar to those of the Multicenter Unsustained Tachycardia Trial (MUSTT trial). Therefore, we compared the predictive power of CRS and conventional PVS using the values of 35% VT/VF inducibility during PVS in NSVT patients, and a 33% and 50% increase in all-cause and arrhythmic mortality, respectively, associated with VT/VF inducibility in MUSTT. Projecting the predictive power of PVS in MUSTT into the EMIAT population yielded a sensitivity of 13.8% and 14.0% and positive predictive value (PPV) of 27.9% and 14.0% for all-cause and arrhythmic mortality, respectively, whereas an abnormal CRS was associated with sensitivities of 46.0% and 46.5% and PPV of 37.4% and 18.7%. Compared with the noninvasive Holter-based CRS, invasive PVS appears inferior in the identification of high-risk post-MI patients with left ventricular dysfunction.
- 590 __
- $a bohemika - dle Pubmed
- 650 12
- $a elektrokardiografie ambulantní $7 D015716
- 650 02
- $a elektrofyziologie $7 D004594
- 650 02
- $a ženské pohlaví $7 D005260
- 650 12
- $a srdeční frekvence $7 D006339
- 650 02
- $a lidé $7 D006801
- 650 02
- $a mužské pohlaví $7 D008297
- 650 02
- $a lidé středního věku $7 D008875
- 650 02
- $a infarkt myokardu $x mortalita $x patofyziologie $7 D009203
- 650 02
- $a prediktivní hodnota testů $7 D011237
- 650 02
- $a hodnocení rizik $7 D018570
- 655 _2
- $a srovnávací studie $7 D003160
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Šimek, Jan, $d 1973- $7 xx0114927 $u Third Department of Internal Medicine, General University Hospital, Prague, Czech Republic
- 700 1_
- $a Camm, A. John $7 nlk20050167154 $u Department of Cardiac and Vascular Sciences, St. George's Hospital Medical School, London, UK
- 700 1_
- $a Malík, Marek, $d 1951- $7 xx0098959 $u Department of Cardiac and Vascular Sciences, St. George's Hospital Medical School, London, UK
- 773 0_
- $t Pacing and clinical electrophysiology $x 0147-8389 $g č. 28 Suppl 1 (2005), s. S182-S186 $p Pacing Clin Electrophysiol $w MED00003671
- 773 0_
- $p Pacing Clin Electrophysiol $g 28 Suppl 1:S182-6, 2005 Jan $x 0147-8389
- 910 __
- $a ABA008 $y 3 $z 0
- 990 __
- $a 20131001090600 $b ABA008
- 991 __
- $a 20131002102022 $b ABA008
- 999 __
- $a ok $b bmc $g 995375 $s 829733
- BAS __
- $a 3
- BMC __
- $a 2005 $c 28 Suppl 1 $d S182-S186 $i 0147-8389 $m Pacing and clinical electrophysiology $x MED00003671 $n Pacing Clin Electrophysiol
- GRA __
- $a NR8146 $p MZ0
- LZP __
- $a 2013-10/dpbo